BMS 527 (Sprycel 20 mg)

Generic Name: dasatinib

Pill imprint BMS 527 has been identified as Sprycel 20 mg.

Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BMS 527

Sprycel 20 mg BMS 527
Sprycel
Generic Name:
dasatinib
Imprint:
BMS
527
Strength:
20 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-0527
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)